LYU Hui,WANG Anmin,CHANG Hongyuan,et al.Advantages of treating benign prostatic hyperplasia bsaed on the "brain-heart-kidney-semen chamber"axis[J]. Beijing Journal of Traditional Chinese Medicine,2026,45(03):306-309.
LYU Hui,WANG Anmin,CHANG Hongyuan,et al.Advantages of treating benign prostatic hyperplasia bsaed on the "brain-heart-kidney-semen chamber"axis[J]. Beijing Journal of Traditional Chinese Medicine,2026,45(03):306-309.DOI: 10.16025/j.1674-1307.2026.03.004.
Advantages of treating benign prostatic hyperplasia bsaed on the "brain-heart-kidney-semen chamber"axis
The diagnosis and treatment of benign prostatic hyperplasia (BPH) based on the "brain-heart-kidney-semen chamber" axis theory embodies the holistic concept of Traditional Chinese Medicine (TCM) that emphasizes “visceral coordination and simultaneous treatment of mind and body.” This approach offers unique advantages in alleviating patients' lower urinary tract symptoms and enhancing their quality of life. This theory posits that prostate enlargement constitutes a disorder of essence chamber dysfunction, closely intertwined with the brain, heart, and kidneys. Treatment strategies include calming the spirit and soothing the heart, tonifying the kidneys and consolidating the foundation, and unblocking the essence channels. Specific herbal combinations:such as Polygala-Gardenia-Alisma, Cinnamon-Acorus-Cornus, Ligusticum chuanxiong-Pollen-Plantago seed, among others. Combined with syndrome differentiation and tailored prescriptions, this holistic approach has achieved remarkable clinical efficacy.
Outcomes indicators in randomized controlled trials of traditional Chinese medicine for postinfectious cough
Mechanisms of Guben Yiliu No. 2 in inhibiting postoperative lung metastasis of triple-negative breast cancer mice via the VEGF/ANG pathway
Clinical efficacy of Kushen Tongguan Pills in the treatment of benign prostatic hyperplasia by regulating miRNA21/NF-κB/COX-2 signaling pathway to mediate ferroptosis
Differentiation and treatment of benign prostatic hyperplasia based on the "brain-heart-kidney-essence chamber" axis
Expert consensus on the application of the "brain-heart-kidney-essence chamber" axis in benign prostatic hyperplasia (2025 edition)
Related Author
ZHANG Xinyi
JIN Xin
RENAGULI·Aisikaer
ZHANG Hongchun
ZUO Xi
WANG Xiaomin
NAN Lingshan
YIN Xiaohui
Related Institution
The First Department of Integrative Pulmonology, China-Japan Friendship Hospital
Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Beijing University of Chinese Medicine
Research Office, Ningxia Hui Autonomous Region Hospital of Traditional Chinese Medicine
Department of Urology, Second Hospital of Tianjin Medical University